InflaRx N.V.
IFRX • NASDAQ
InflaRx N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Niels C. Riedemann, with a market cap of $65.9M.
CEONiels C. Riedemann
Next Earnings
Upcoming earnings announcement for InflaRx N.V.
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.17
Revenue Estimate
$40.0K
Earnings History
Past 12 earnings reports for InflaRx N.V.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.17Est: -$0.18 | +5.6% | -$39.5KEst: $230.0K | -117.2% | — |
| Nov 10, 2025 | Q3 2025 | -$0.21Est: -$0.19 | -10.5% | $27.9KEst: $230.0K | -87.9% | — |
| Aug 7, 2025 | Q2 2025 | -$0.24Est: -$0.24 | 0.0% | $44.7KEst: $120.0K | -62.7% | — |
| May 7, 2025 | Q1 2025 | -$0.14Est: -$0.17 | +17.6% | -Est: $34.3K | -100.0% | — |
| Mar 20, 2025 | Q4 2024 | -$0.09Est: -$0.28 | +67.9% | -$451.5KEst: $125.0K | -461.2% | — |
| Nov 8, 2024 | Q3 2024 | -$0.33Est: -$0.27 | -22.2% | $136.1KEst: $90.0K | +51.2% | — |
| Aug 8, 2024 | Q2 2024 | -$0.26Est: -$0.21 | -23.8% | $6.8KEst: $80.0K | -91.4% | — |
| May 8, 2024 | Q1 2024 | -$0.18Est: -$0.24 | +25.0% | $39.1KEst: $1.4M | -97.1% | — |
| Mar 21, 2024 | Q4 2023 | -$0.30Est: -$0.20 | -50.0% | $2.5KEst: $1.4M | -99.8% | — |
| Nov 1, 2023 | Q3 2023 | -$0.14Est: -$0.25 | +44.0% | $66.2KEst: $2.6M | -97.4% | — |
| Aug 10, 2023 | Q2 2023 | -$0.15Est: -$0.34 | +55.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.27Est: -$0.30 | +10.0% | - | — | — |